Avalon GloboCare Corp. Files 8-K: Material Agreement & Equity Sales
Ticker: ALBT · Form: 8-K · Filed: Dec 26, 2024 · CIK: 1630212
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
Avalon GloboCare filed an 8-K on 12/19/24 detailing a material agreement and equity sales.
AI Summary
On December 19, 2024, Avalon GloboCare Corp. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. The filing details are associated with Accession Number 0001213900-24-112412.
Why It Matters
This 8-K filing indicates significant corporate activity for Avalon GloboCare Corp., including a new material agreement and equity transactions, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Numbers
- 20241219 — Report Date (Earliest event reported in the 8-K filing.)
- 20241226 — Filing Date (Date the 8-K was publicly filed.)
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- December 19, 2024 (date) — Date of earliest event reported
- 0001213900-24-112412 (accession_number) — Filing identifier
- Delaware (jurisdiction) — State of incorporation
- 001-38728 (commission_file_number) — SEC File Number
- 47-1685128 (irs_number) — I.R.S. Employer Identification Number
- 4400 Route 9 South, Suite 3100, Freehold, NJ 07728 (address) — Business and Mail Address
FAQ
What type of material definitive agreement did Avalon GloboCare Corp. enter into on December 19, 2024?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What was the nature of the unregistered sales of equity securities reported?
The filing mentions unregistered sales of equity securities, but the specifics regarding the number of shares, price, or terms are not detailed in the provided excerpt.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on December 26, 2024, as indicated by the 'FILED AS OF DATE' and 'DATE AS OF CHANGE'.
What is Avalon GloboCare Corp.'s primary business classification?
Avalon GloboCare Corp. is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code [2836].
Has Avalon GloboCare Corp. operated under different names previously?
Yes, the company was formerly known as Avalon Globocare Corp. (name change on 20161018) and prior to that, GLOBAL TECHNOLOGIES CORP (name change on 20150108).
Filing Stats: 1,009 words · 4 min read · ~3 pages · Grade level 12.9 · Accepted 2024-12-26 09:00:06
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Capital M
- $1,000 — e Preferred Stock has a stated value of $1,000 (the "Stated Value"). On December 19,
- $7,000,000 — eferred Stock for up to an aggregate of $7,000,000 (the "Purchase Price"), which is equal
- $3,500,000 — ertible Preferred Stock in exchange for $3,500,000. Each share of Series C Convertible Pr
- $2 — es") at a conversion per share equal to $2.41, at the option of the holder, at any
Filing Documents
- ea0225900-8k_avalon.htm (8-K) — 30KB
- ea022590001ex10-1_avalon.htm (EX-10.1) — 93KB
- 0001213900-24-112412.txt ( ) — 322KB
- albt-20241219.xsd (EX-101.SCH) — 3KB
- albt-20241219_lab.xml (EX-101.LAB) — 33KB
- albt-20241219_pre.xml (EX-101.PRE) — 22KB
- ea0225900-8k_avalon_htm.xml (XML) — 4KB
02. Unregistered
Item 3.02. Unregistered Sales of Equity Securities. The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. The securities described above have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any state, and were offered and sold in reliance on the exemption from registration under the Securities Act afforded by Section 4(a)(2) thereof.
01. Financial
Item 9.01. Financial (d) Exhibits Exhibit No. Description 10.1 Securities Purchase Agreement, between the Company and Holder, dated as of December 19, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: December 26, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer 2